OurCrowd Enhances Investment in Seed, Early-Stage Startups


Global investment platform OurCrowd is intensifying its incubator and early-stage investment activity to grow early stage tech companies.

Led by CEO Jon Medved, OurCrowd is a global crowdfunding venture investing platform and Israel’s venture investor, which invests in – and already operates – five tech incubators with partners in Israel and globally.

OurCrowd has competed for, and over the last two years has won, government licenses to operate four incubators in Israel, together with an array of leading partners. These include:

  • Labs/02 in Jerusalem (with Reliance Industries and in collaboration with Hebrew University’s Yissum);
  • Labs/08 in Beersheva (with Reliance Industries the owner of Jio telecommunications company, and in collaboration with Soroka Medical Center, and the Israel National Cyber Directorate);
  • Freshstart in Kiryat Shemonah (with Tnuva, Tempo, and Finistere Ventures); and
  • CanNegev in Yeruacham (with Perrigo and BoL Pharma).

In addition, the firm recently announced its participation in a global consortium to run an agtech/foodtech incubator in New Zealand together with Sprout, Finistere, Fontera, and Gallagher. This is the first of a planned major expansion of incubator opportunities globally.

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 20 venture funds, OurCrowd offers access to its membership of 41,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms. Its portfolio is diversified across sectors and stages, ranging from seed and series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel.



Join the discussion